Haoxi Health Technology Limited (HAO)

NASDAQ: HAO · IEX Real-Time Price · USD

3.960

-1.010 (-20.32%)

At close: Jul 19, 2024, 4:00 PM

4.220

+0.260 (6.57%)

Pre-market: Jul 22, 2024, 7:14 AM EDT

Haoxi Health Technology Income Statement

Financials in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Year Ending	TTM	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Revenue	42.57	28.23	16.16	12.85
Revenue Growth (YoY)	231.35%	74.72%	25.76%	-
Cost of Revenue	40.04	26.17	-15.51	12.24
Gross Profit	2.53	2.06	31.67	0.61
Selling, General & Admin	0.95	0.81	0.28	0.21
Research & Development	0.07	0.06	0.1	0.06
Operating Expenses	1.01	0.87	0.38	0.28
Operating Income	1.52	1.2	31.29	0.33
Interest Expense / Income	0.03	0.02	0.01	0.01
Other Expense / Income	-0.01	-0.02	31.02	-
Pretax Income	1.5	1.19	0.26	0.33
Income Tax	0.22	0.22	0.02	0.02
Net Income	1.28	0.97	0.24	0.3
Net Income Growth	321.92%	296.49%	-19.56%	-
Shares Outstanding (Basic)	29	28	25	25
Shares Outstanding (Diluted)	29	28	25	25
Shares Change	17.92%	10.45%	-	-
EPS (Basic)	0.05	0.04	0.01	0.01
EPS (Diluted)	0.05	0.04	0.01	0.01
EPS Growth	333.33%	300.00%	-16.67%	-
Free Cash Flow	-	-0.92	-0.68	2.65
Free Cash Flow Per Share	-	-0.03	-0.03	0.11
Gross Margin	5.95%	7.30%	195.98%	4.71%
Operating Margin	3.57%	4.24%	193.63%	2.57%
Profit Margin	3.01%	3.44%	1.51%	2.37%
Free Cash Flow Margin	-	-3.25%	-4.23%	20.59%
Effective Tax Rate	14.73%	18.54%	5.78%	6.52%
EBITDA	-	1.22	0.27	0.33
EBITDA Margin	-	4.32%	1.68%	2.58%
Depreciation & Amortization	-	0.01	0	0
EBIT	1.54	1.21	0.27	0.33
EBIT Margin	3.61%	4.29%	1.67%	2.57%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).